RAPS recognizes that the current situation in Ukraine impacts our members and customers on many levels. If you are directly impacted by the current situation in the region and are challenged to meet your deadlines or obligations to RAPS, please reach out to raps@raps.org so that we can defer those challenges. Your health and safety are paramount to us.

Regulatory Focus™ > News Articles > China Signs MOU with the Netherlands

China Signs MOU with the Netherlands

Posted 07 May 2012

China's State Food and Drug Administration has further expanded its international collaborative efforts in regulatory matters by concluding a Memorandum of Understanding (MOU) with the Ministry of Health of the Netherlands.

The new MOU calls for expanded cooperation between the two countries on matters relating to the regulation of drugs and medical devices.

A Dutch company had exported to China breast implants containing industrial grade silicone that were supplied by the French manufacturer of the faulty implants, Poly Implant Prothese (PIP).

Read more:
Discipline inspection group leader 中央纪委驻 Bureau Yin into access to the Netherlands Institute for Health Supervision Bureau and the signing of the Memorandum of Understanding - China's State Food and Drug Administration


© 2022 Regulatory Affairs Professionals Society.